A. Sarivalasis

Discipline

Economies et finances (2) Psychologie (1) Sciences de l'information et de la communication (1)

Type de document

Articles (19) Recensions (9) Mémoires, Thèses et HDR (1)

Co-auteur

Date

Source

Mot-clé

Patients (15) Treatment (14) Patients (14) Cancer (12) cancer (10) Cancer (10) Immunotherapy (8) Immunotherapy (8) Diagnosis (6) Chemotherapy (6) Article (6) Tumors (6) Human beings (6) Grammar, Comparative and general--Article (6) Diagnosis (6) Chemotherapy (6) Article (6) Relapse (6) thérapie (5) oncologie (5) Surgery (5) Therapeutics (5) Surgery (5) Risk (5) Oncology (5) Months (5) Tumors (5) risque (4) gestion (4) littérature (4)

Documents écrit par A. Sarivalasis (20) | parle de A. Sarivalasis (0)

Cancer de l’endomètre : entre modernité et immunothérapie [Endometrial cancer in the crossroads of modernity and immunotherapy]
B. Giacomuzzi Moore et al. (17 mai 2023)
Lymph Node Involvement in Recurrent Serous Borderline Ovarian Tumors: Current Evidence, Controversies, and a Review of the Literature.
L. Wetterwald et al. (31 janv. 2023)
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.
C. Bandiera et al. (3 janv. 2023)
Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy.
B. Mastelic-Gavillet et al. (2023)
Traitements intrapéritonéaux de la carcinose ovarienne : proposition d’algorithmes décisionnels [Intraperitoneal therapy for carcinomatosis in ovarian cancer: proposed treatment algorithm]
M. Undurraga et al. (18 mai 2022)
Oncologie [2021 Oncology update]
M.L. Meyer et al. (2 févr. 2022)
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
F.G. Herrera et al.
A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma.
A. Harari et al. (18 nov. 2021)
A Locally Advanced Endometrioid Adenocarcinoma Arising from Vaginal Endometriosis: Management and Review of the Literature
M. Costanza et al. (17 sept. 2021)
Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human.
C.L. Chiang et al. (10 sept. 2021)
VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.
A. Liapi et al.
Oncologie [2020 oncology update]
G. Dei Tos et al. (27 janv. 2021)
Cell therapies in ovarian cancer.
A. Sarivalasis et al. (2021)
So-Called Serous Carcinoma of the Uterine Cervix with BRCA2 Mutation: Case Report and Review of the Literature.
R.G. Herrera Gómez et al. (2021)
Oncologie [Advances in Oncology 2019]
A. Vernadou et al. (15 janv. 2020)
Oncologie [Advances in Oncology 2019]
A. Vernadou et al. (15 janv. 2020)
Paraneoplastic Cerebellar Ataxia Can Affect Prognosis in High-Grade Serous Ovarian Cancer: A Case Report.
A. Liapi et al. (2020)
Primary Care-Led Transition Clinics Hold Promise in Improving Care Transitions for Cancer Patients Facing Social Disparities: A Commentary.
M. Malebranche et al. (2020)
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma.
A. Sarivalasis et al. (26 nov. 2019)
Dépistage et traitement de l'infection tuberculeuse latente chez les requérants d'asile récemment arrivés dans le canton de Vaud
A. SARIVALASIS (2013)